Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Prednisone
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical Center
P2
B
(60)
Prednisone
Prostate Small Cell Carcinoma
Fred Hutchinson Cancer Center
P2
B
(60)
Progerinin
Hutchinson-Gilford Progeria Syndrome
PRG Science & Technology Co., Ltd.
P2
B
(60)
Progerinin
Werner Syndrome
PRG Science & Technology Co., Ltd.
P2
B
(60)
Pumvc3-Igfbp2-Her2-Igf1R Plasmid Dna Vaccine
Breast Cancer
University of Washington
P2
B
(60)
Quizartinib
Childhood Acute Myeloid Leukemia
Princess Maxima Center for Pediatric Oncology
P2
B
(60)
Recombinant Human Granulocyte Colony-Stimulating Factor
Acute Myeloid Leukemia
City of Hope Medical Center
P2
B
(60)
Recombinant Human Hyaluronidase
B-Cell Non-Hodgkin Lymphoma
Academic and Community Cancer Research United
P2
B
(60)
Recombinant Human Hyaluronidase
Marginal Zone Lymphoma
Academic and Community Cancer Research United
P2
B
(60)
Recombinant Human Hyaluronidase
Plasma Cell Myeloma
National Cancer Institute (NCI)
P2
B
(60)
Regorafenib
Cancer
West China Hospital
P2
B
(60)
Regorafenib
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
B
(60)
Regorafenib
Castration-Resistant Prostate Carcinoma
Translational Research in Oncology
P2
B
(60)
Regorafenib
Digestive System Neuroendocrine Neoplasm
Translational Research in Oncology
P2
B
(60)
Regorafenib
Hematopoietic And Lymphoid System Neoplasm
Helsinki University Central Hospital
P2
B
(60)
Regorafenib
Malignant Pancreatic Neoplasm
Junjie Hang
P2
B
(60)
Regorafenib
Rectal Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Relatlimab
Nonpapillary Renal Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Relatlimab
Ureter Transitional Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Relatlimab
Urothelial Carcinoma
Exelixis
P2
B
(60)
Retifanlimab
Malignant Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(60)
Revumenib
Acute Myeloid Leukemia, MLL Gene Rearrangement
National Cancer Institute (NCI)
P2
B
(60)
Ribociclib
Diffuse Midline Glioma, H3 K27M-Mutant
Nationwide Children's Hospital
P2
B
(60)
Ribociclib
Metastatic Malignant Neoplasm In The Brain
Nationwide Children's Hospital
P2
B
(60)
Rituximab
ALK-Positive Large B-Cell Lymphoma
Mayo Clinic
P2
B
(60)
Showing 2126 to 2150 of 13,155 assets
Previous
Page 86 of 527
Next